Helminth mediated modulation of Type 1 diabetes (T1D)

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 311-318

  Zaccone, Paola ^a   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Helminth; IL 10; NKT; Regulatory T cells; TGF ; Type 1 diabetes

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 10; PARASITE ANTIGEN; POLYINOSINIC POLYCYTIDYLIC ACID; TRANSFORMING GROWTH FACTOR BETA;

DIABETES; ENDOPARASITE; MODELING; PUBLIC HEALTH; RODENT; SANITATION;

AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CELL EXPANSION; CYTOKINE PRODUCTION; DENDRITIC CELL; DIROFILARIA IMMITIS; DISEASE MODEL; HELIGMOSOMOIDES POLYGYRUS; HELMINTHIASIS; IMMUNE RESPONSE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LITOMOSOIDES SIGMODONTIS; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMA MANSONI; T LYMPHOCYTE; TH2 CELL; THERAPY WITH HELMINTHS; TRICHINELLA SPIRALIS; VIRUS INFECTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HELMINTH PROTEINS; HELMINTHS; HUMANS; THERAPY WITH HELMINTHS;

ANIMALIA; RODENTIA; VERMES;

EID: 84873741223     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.12.004     Document Type: Review

References (112)

1. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2012, 11:375-388.
2. Aspock H., Auer H., Picher O. Trichuris trichiura eggs in the neolithic glacier mummy from the Alps. Parasitol. Today 1996, 12:255-256.
3. Atochina O., Harn D. Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp. Dermatol. 2006, 15:461-468.
4. Baecher-Allan C., Anderson D.E. Regulatory cells and human cancer. Semin. Cancer Biol. 2006, 16:98-105.
5. Barron L., Wynn T.A. Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G723-728.
6. Banting F.G., Best C.H. The internal secretion of the pancreas. J. Lab. Clin. Med. 1922, 7:465-480.
7. Baxter A.G., Horsfall A.C., Healey D., Ozegbe P., Day S., Williams D.G., Cooke A. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994, 83:227-231.
8. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
9. Berzins S.P., Smyth M.J., Baxter A.G. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 2011, 11:131-142.
10. Beyer M., Schultze J.L. Regulatory T cells in cancer. Blood 2006, 108:804-811.
11. Botelho M., Oliveira P., Gomes J., Gartner F., Lopes C., da Costa J.M., Machado J.C. Tumourigenic effect of Schistosoma haematobium total antigen in mammalian cells. Int. J. Exp. Pathol. 2009, 90:448-453.
12. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009, 10:321-322.
13. Bras A., Aguas A.P. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 1996, 89:20-25.
14. Broadhurst M.J., Leung J.M., Lim K.C., Girgis N.M., Gundra U.M., Fallon P.G., Premenko-Lanier M., McKerrow J.H., McCune J.M., Loke P. Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent Type-2 immunity to helminth infection in mice. PLoS Pathog. 2012, 8:e1002883.
15. Brusko T.M., Wasserfall C.H., Clare-Salzler M.J., Schatz D.A., Atkinson M.A. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 2005, 54:1407-1414.
16. Brusko T., Wasserfall C., McGrail K., Schatz R., Viener H.L., Schatz D., Haller M., Rockell J., Gottlieb P., Clare-Salzler M., Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 2007, 56:604-612.
17. Burton O.T., Gibbs S., Miller N., Jones F.M., Wen L., Dunne D.W., Cooke A., Zaccone P. Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur. J. Immunol. 2010, 40:2221-2229.
18. Chen Y.G., Choisy-Rossi C.M., Holl T.M., Chapman H.D., Besra G.S., Porcelli S.A., Shaffer D.J., Roopenian D., Wilson S.B., Serreze D.V. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 2005, 174:1196-1204.
19. Cooke A., Tonks P., Jones F.M., O'Shea H., Hutchings P., Fulford A.J., Dunne D.W. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999, 21:169-176.
20. D'Alise A.M., Auyeung V., Feuerer M., Nishio J., Fontenot J., Benoist C., Mathis D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 2008, 105:19857-19862.
21. Daniel C., von Boehmer H. Extra-thymically induced regulatory T cells: do they have potential in disease prevention?. Semin. Immunol. 2011, 23:410-417.
22. Davydova B., Harkonen T., Kaialainen S., Hovi T., Vaarala O., Roivainen M. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J. Med. Virol. 2003, 69:510-520.
23. Driver J.P., Serreze D.V., Chen Y.G. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin. Immunopathol. 2011, 33:67-87.
24. Dunne D.W., Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat. Rev. Immunol. 2005, 5:420-426.
25. Elias D., Akuffo H., Pawlowski A., Haile M., Schon T., Britton S. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 2005, 23:1326-1334.
26. Everts B., Perona-Wright G., Smits H.H., Hokke C.H., van der Ham A.J., Fitzsimmons C.M., Doenhoff M.J., van der Bosch J., Mohrs K., Haas H., Mohrs M., Yazdanbakhsh M., Schramm G. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J. Exp. Med. 2009, 206:1673-1680.
27. Everts B., Hussaarts L., Driessen N.N., Meevissen M.H., Schramm G., van der Ham A.J., van der Hoeven B., Scholzen T., Burgdorf S., Mohrs M., Pearce E.J., Hokke C.H., Haas H., Smits H.H., Yazdanbakhsh M. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J. Exp. Med. 2012, 209:1753-1767.
28. Faveeuw C., Mallevaey T., Trottein F. Role of natural killer T lymphocytes during helminthic infection. Parasite 2008, 15:384-388.
29. Filippi C.M., Estes E.A., Oldham J.E., von Herrath M.G. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J. Clin. Invest. 2009, 119:1515-1523.
30. Fletcher M.T., Baxter A.G. Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus. Immunol. Cell Biol. 2009, 87:315-323.
31. Francisco L.M., Sage P.T., Sharpe A.H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 2010, 236:219-242.
32. Goncalves M.L., Araujo A., Ferreira L.F. Human intestinal parasites in the past: new findings and a review. Mem. Inst. Oswaldo Cruz 2003, 98(Suppl 1):103-118.
33. Graham K.L., O'Donnell J.A., Tan Y., Sanders N., Carrington E.M., Allison J., Coulson B.S. Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset. J. Virol. 2007, 81:6446-6458.
34. Graham K.L., Sanders N., Tan Y., Allison J., Kay T.W., Coulson B.S. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J. Virol. 2008, 82:6139-6149.
35. Hams E., McCarron M.J., Amu S., Yagita H., Azuma M., Chen L., Fallon P.G. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells. J. Immunol. 2011, 186:5648-5655.
36. Harada M., Kishimoto Y., Makino S. Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res. Clin. Pract. 1990, 8:85-89.
37. Harn D.A., McDonald J., Atochina O., Da'dara A.A. Modulation of host immune responses by helminth glycans. Immunol. Rev. 2009, 230:247-257.
38. Harrison L.C. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol. Cell Biol. 2008, 86:139-145.
39. Hong S., Wilson M.T., Serizawa I., Wu L., Singh N., Naidenko O.V., Miura T., Haba T., Scherer D.C., Wei J., Kronenberg M., Koezuka Y., Van Kaer L. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001, 7:1052-1056.
40. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
41. Huber S., Hoffmann R., Muskens F., Voehringer D. Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 2010, 116:3311-3320.
42. Hubner M.P., Stocker J.T., Mitre E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 2009, 127:512-522.
43. Hubner M.P., Shi Y., Torrero M.N., Mueller E., Larson D., Soloviova K., Gondorf F., Hoerauf A., Killoran K.E., Stocker J.T., Davies S.J., Tarbell K.V., Mitre E. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J. Immunol. 2012, 188:559-568.
44. Imai S., Tezuka H., Fujita K. A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem. Biophys. Res. Commun. 2001, 286:1051-1058.
45. Inagaki-Ohara K., Sakamoto Y., Dohi T., Smith A.L. Gammadelta T cells play a protective role during infection with Nippostrongylus brasiliensis by promoting goblet cell function in the small intestine. Immunology 2011, 134:448-458.
46. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012, 30:531-564.
47. Kadri N., Korpos E., Gupta S., Briet C., Lofbom L., Yagita H., Lehuen A., Boitard C., Holmberg D., Sorokin L., Cardell S.L. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes. J. Immunol. 2012, 188:3138-3149.
48. Kis J., Engelmann P., Farkas K., Richman G., Eck S., Lolley J., Jalahej H., Borowiec M., Kent S.C., Treszl A., Orban T. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J. Leukoc. Biol. 2007, 81:654-662.
49. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 2002, 109:131-140.
50. Lee B.J., Kim S.K., Kim M.K., Park E.S., Cho H.C., Shim M.S., Kim M.J., Shin Y.G., Chung C.H. Limited effect of CpG ODN in preventing type 1 diabetes in NOD mice. Yonsei Med. J. 2005, 46:341-346.
51. Lee P.T., Putnam A., Benlagha K., Teyton L., Gottlieb P.A., Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002, 110:793-800.
52. Leslie M. Immunology. Regulatory T cells get their chance to shine. Science 2011, 332:1020-1021.
53. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005, 54:92-99.
54. Liu J.Y., Li L.Y., Yang X.Z., Li J., Zhong G., Wang J., Li L.J., Ji B., Wu Z.Q., Liu H., Yang X., Liu P.M. Adoptive transfer of dendritic cells isolated from helminth-infected mice enhanced T regulatory cell responses in airway allergic inflammation. Parasite Immunol. 2011, 33:525-534.
55. Liu Q., Sundar K., Mishra P.K., Mousavi G., Liu Z., Gaydo A., Alem F., Lagunoff D., Bleich D., Gause W.C. Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect. Immun. 2009, 77:5347-5358.
56. Long S.A., Cerosaletti K., Bollyky P.L., Tatum M., Shilling H., Zhang S., Zhang Z.Y., Pihoker C., Sanda S., Greenbaum C., Buckner J.H. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010, 59:407-415.
57. Ly D., Mi Q.S., Hussain S., Delovitch T.L. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J. Immunol. 2006, 177:3695-3704.
58. MacDonald A.S., Straw A.D., Dalton N.M., Pearce E.J. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J. Immunol. 2002, 168:537-540.
59. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980, 29:1-13.
60. Mallevaey T., Fontaine J., Breuilh L., Paget C., Castro-Keller A., Vendeville C., Capron M., Leite-de-Moraes M., Trottein F., Faveeuw C. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect. Immun. 2007, 75:2171-2180.
61. Mi Q.S., Ly D., Zucker P., McGarry M., Delovitch T.L. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes 2004, 53:1303-1310.
62. Michalek J., Vrabelova Z., Hrotekova Z., Kyr M., Pejchlova M., Kolouskova S., Faresjo M., Stechova K. Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus. Scand. J. Immunol. 2006, 64:531-535.
63. Mills K.H., McGuirk P. Antigen-specific regulatory T cells-their induction and role in infection. Semin. Immunol. 2004, 16:107-117.
64. Mishra, P.K., Patel, N., Wu, W., Bleich, D., Gause, W.C., 2012. Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response. Mucosal Immunol. (Epub ahead of print). http://dx.doi.org/10.1038/mi.2012.71.
65. Montoya C.J., Pollard D., Martinson J., Kumari K., Wasserfall C., Mulder C.B., Rugeles M.T., Atkinson M.A., Landay A.L., Wilson S.B. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007, 122:1-14.
66. Naumov Y.N., Bahjat K.S., Gausling R., Abraham R., Exley M.A., Koezuka Y., Balk S.B., Strominger J.L., Clare-Salzer M., Wilson S.B. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001, 98:13838-13843.
67. Novak, J., Novakova, L., 2012. Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells. Clin. Exp. Med. (Epub ahead of print). http://dx.doi.org/10.1007/s10238-012-0199-0.
68. Oikawa Y., Shimada A., Yamada S., Motohashi Y., Nakagawa Y., Irie J., Maruyama T., Saruta T. High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes. Diabetes Care 2002, 25:1818-1823.
69. Oldstone M.B. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 1990, 171:2077-2089.
70. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
71. Pineda M.A., McGrath M.A., Smith P.C., Al-Riyami L., Rzepecka J., Gracie J.A., Harnett W., Harnett M.M. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. Arthritis Rheum. 2012, 64:3168-3178.
72. Pot C., Apetoh L., Kuchroo V.K. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 2011, 23:202-208.
73. Poulton L.D., Smyth M.J., Hawke C.G., Silveira P., Shepherd D., Naidenko O.V., Godfrey D.I., Baxter A.G. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 2001, 13:887-896.
74. Quintana F.J., Rotem A., Carmi P., Cohen I.R. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice. modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 2000, 165:6148-6155.
75. Redondo M.J., Fain P.R., Eisenbarth G.S. Genetics of type 1A diabetes. Recent Prog. Horm. Res. 2001, 56:69-89.
76. Ritter M., Gross O., Kays S., Ruland J., Nimmerjahn F., Saijo S., Tschopp J., Layland L.E., Prazeres da Costa C. Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proc. Natl. Acad. Sci. USA 2010, 107:20459-20464.
77. Roman-Gonzalez A., Moreno M.E., Alfaro J.M., Uribe F., Latorre-Sierra G., Rugeles M.T., Montoya C.J. Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum. Immunol. 2009, 70:262-268.
78. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990, 39:583-589.
79. Sai P., Rivereau A.S. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Diabetes Metab. 1996, 22:341-348.
80. Saunders K.A., Raine T., Cooke A., Lawrence C.E. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect. Immun. 2007, 75:397-407.
81. Schramm G., Mohrs K., Wodrich M., Doenhoff M.J., Pearce E.J., Haas H., Mohrs M. Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo. J. Immunol. 2007, 178:6023-6027.
82. Semenya A.A., Sullivan J.S., Barnwell J.W., Secor W.E. Schistosoma mansoni infection impairs antimalaria treatment and immune responses of rhesus macaques infected with mosquito-borne Plasmodium coatneyi. Infect. Immun. 2012, 80:3821-3827.
83. Serreze D.V., Hamaguchi K., Leiter E.H. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 1989, 2:759-776.
84. Serreze D.V., Ottendorfer E.W., Ellis T.M., Gauntt C.J., Atkinson M.A. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000, 49:708-711.
85. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Sondhi J., Naidenko O.V., Kronenberg M., Koezuka Y., Delovitch T.L., Gombert J.M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A., Bach J.F., Herbelin A. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001, 7:1057-1062.
86. Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 2007, 8:239-245.
87. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 2007, 117:1155-1166.
88. Smith K.A., Efstathiou S., Cooke A. Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J. Immunol. 2007, 179:7325-7333.
89. Smith K.A., Hochweller K., Hammerling G.J., Boon L., MacDonald A.S., Maizels R.M. Chronic helminth infection promotes immune regulation in vivo through dominance of CD11cloCD103-dendritic cells. J. Immunol. 2011, 186:7098-7109.
90. Smith P., Walsh C.M., Mangan N.E., Fallon R.E., Sayers J.R., McKenzie A.N., Fallon P.G. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J. Immunol. 2004, 173:1240-1248.
91. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2012, 12:21-27.
92. Steinfelder S., Andersen J.F., Cannons J.L., Feng C.G., Joshi M., Dwyer D., Caspar P., Schwartzberg P.L., Sher A., Jankovic D. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med. 2009, 206:1681-1690.
93. Szypowska A., Stelmaszczyk-Emmel A., Demkow U., Luczynski W. Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60:307-313.
94. Takei I., Asaba Y., Kasatani T., Maruyama T., Watanabe K., Yanagawa T., Saruta T., Ishii T. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmun. 1992, 5:665-673.
95. Taylor M.D., van der Werf N., Maizels R.M. T cells in helminth infection: the regulators and the regulated. Trends Immunol. 2012, 33:181-189.
96. Toyota T., Satoh J., Oya K., Shintani S., Okano T. Streptococcal preparation (OK-432) inhibits development of type I diabetes in NOD mice. Diabetes 1986, 35:496-499.
97. Tracy S., Drescher K.M., Chapman N.M., Kim K.S., Carson S.D., Pirruccello S., Lane P.H., Romero J.R., Leser J.S. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 2002, 76:12097-12111.
98. Tracy S., Drescher K.M., Jackson J.D., Kim K., Kono K. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev. Med. Virol. 2010, 20:106-116.
99. Tsutsumi Y., Jie X., Ihara K., Nomura A., Kanemitsu S., Takada H., Hara T. Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes. Diabet. Med. 2006, 23:1145-1150.
100. Tupin E., Kinjo Y., Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 2007, 5:405-417.
101. van Die I., Cummings R.D. Glycan gimmickry by parasitic helminths: a strategy for modulating the host immune response?. Glycobiology 2010, 20:2-12.
102. van Liempt E., van Vliet S.J., Engering A., Garcia Vallejo J.J., Bank C.M., Sanchez-Hernandez M., van Kooyk Y., van Die I. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 2007, 44:2605-2615.
103. Wilberz S., Partke H.J., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991, 34:2-5.
104. Wilson S.B., Kent S.C., Patton K.T., Orban T., Jackson R.A., Exley M., Porcelli S., Schatz D.A., Atkinson M.A., Balk S.P., Strominger J.L., Hafler D.A. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998, 391:177-181.
105. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010, 11:7-13.
106. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
107. Yazdanbakhsh M., Kremsner P.G., van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
108. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., Cooke A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 2003, 33:1439-1449.
109. Zaccone P., Raine T., Sidobre S., Kronenberg M., Mastroeni P., Cooke A. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur. J. Immunol. 2004, 34:3246-3256.
110. Zaccone P., Burton O., Miller N., Jones F.M., Dunne D.W., Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 2009, 39:1098-1107.
111. Zaccone P., Burton O.T., Gibbs S., Miller N., Jones F.M., Dunne D.W., Cooke A. Immune modulation by Schistosoma mansoni antigens in NOD mice. Effects on both innate and adaptive immune systems. J. Biomed. Biotechnol. 2010, 2010:795210.
112. Zaccone P., Burton O.T., Gibbs S.E., Miller N., Jones F.M., Schramm G., Haas H., Doenhoff M.J., Dunne D.W., Cooke A. The S. mansoni glycoprotein omega-1 induces Foxp3 expression in NOD mouse CD4(+) T cells. Eur. J. Immunol. 2011, 41:2709-2718.